The combination of ezetimibe and simvastatin is currently the only product to treat both sources of cholesterol; absorption in the intestine of both biliary and dietary cholesterol, and production in the liver and peripheral tissues. It is thought that the treatment of high cholesterol from both sources is likely to result in lower cholesterol levels, particularly LDL cholesterol. In a clinical study, it was shown that the combination of ezetimibe and simvastatin was superior to atorvastatin in lowering LDL cholesterol.
Ezetimibe/simvastatin
Ezetimibe/atorvastatin
Bempedoic acid/ezetimibe
Ezetimibe/rosuvastatin
Fenofibrate/simvastatin
Fenofibrate/pravastatin
Amlodipine/atorvastatin
Sitagliptin/metformin